| Date Filed | Type | Description |
| 03/02/2023 |
4
| Reed Joshua (CFO) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/06/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2019 |
4
| Reed Joshua (CFO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 29,637 shares
@ $0
Granted 250,000 options to buy
@ $8.05, valued at
$2M
|
|
| 08/01/2018 |
4
| Reed Joshua (CFO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.8, valued at
$510k
|
|
| 08/01/2018 |
3
| Reed Joshua (CFO) has filed a Form 3 on Aldeyra Therapeutics, Inc. |